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ABSTRACT
Objective: This study aims to assess the impact of diabetes mellitus (DM)
on the health-care utilization and clinical outcomes of patients with acute
stroke.
Methods: This is a retrospective cohort study. All patients who were
admitted for the ﬁrst time to one of the three public hospitals in the
National Healthcare Group in Singapore from January 2005 to June 2007
with a primary diagnosis of acute stroke were included and were followed
up for 1 year after the index hospitalization. The study population was
divided into two groups: with DM and without DM. Both univariate and
multivariate analyses were applied to compare the hospital length of stay
(LOS), hospitalization costs, mortality, as well as the 1-year hospital
readmissions between the DM and non-DM groups.
Results: There were 9766 study patients, and 38.5% of them had DM.
DM patients with ischemic stroke (IS) and transient ischemic attack
(TIA) stayed 1-day and 0.6-day longer, and incurred 10% and 26% higher
hospital cost during index admission, respectively, compared with their
counterparts in the non-DM group. They also had more hospital readmis-
sion within 1 year. The mortality rate in IS patients with diabetes was 24%
higher. After risk adjustment, subarachnoid hemorrhage patients with
diabetes had more hospitalizations. Intracerebral hemorrhage (ICH) and
IS patients in the DM group had all worse outcomes but the 1-year
stroke recurrence; TIA patients with DM incurred longer LOS and hospi-
tal costs.
Conclusion: DM predicts worse clinical outcomes and higher health-care
expenditures in the 1-year poststroke especially for the IS, ICH, and TIA
stroke subtypes.
Keywords: clinical outcomes, diabetes mellitus, health-care utilization,
stroke.
Introduction
Stroke is one of the leading causes of mortality and morbidity in
developed countries. Diabetes mellitus (DM) is a well-recognized
risk factor for ischemic stroke (IS) [1,2]. The signiﬁcance of DM
as a risk factor for hemorrhagic stroke could differ depending on
ethnicity [1,2].
DM has been independently associated with some forms of
large artery disease and with small artery infarctions detected by
neuroimaging studies [1–4]. DM signiﬁcantly increases the risk
of stroke, but it is not clear how DM affects the clinical and
functional outcomes. In some studies, stroke patients with DM
were reported to be associated with reduced survival after stroke
[5–9], worse clinical and functional outcomes, and more health-
care utilization [6–9], but in some other studies, the impact was
not signiﬁcant [10,11].
Stroke is the fourth leading cause of death and hospitaliza-
tion, as well as the biggest cause of long-term disability in Sin-
gapore [12,13]. According to the Singapore National Health
Survey in 2004, the prevalence rate of DM in the whole popu-
lation was about 8.2%, and the rate was 17.9% in the popula-
tion aged 40 years [14]. There are about 10,000 stroke incidences
annually, and more than 30% stroke patients also have DM [13].
It is not known how DM affects the health-care utilization and
clinical outcomes of stroke patients in Singapore.
The objective of this study is to assess the impact of DM as
a comorbid condition on the health-care utilization (hospital
length of stay [LOS] and cost of the index hospital admission,
and total cost of hospital admissions within 1 year of the index
admission due to any reason other than DM and its related
complications) and the clinical outcomes (mortality of index
admission, 1-year hospital readmission rate due to stroke recur-
rence, and 1-year hospital readmission due to any reason other
than DM or DM-related complications) among patients hospi-
talized with different subtypes of acute strokes in Singapore.
Methodology
Study Design
This is a retrospective cohort study. In Singapore, the National
Healthcare Group (NHG) is one of the two public health-care
delivery clusters that manage three acute hospitals, several spe-
cialty centers, and nine primary care clinics serving a population
of 2.2 million. Patients admitted to one of the three public
hospitals in the NHG in Singapore from January 2005 to June
2007 with a primary diagnosis of acute stroke were included and
followed up for 1 year. Patients who had any previous admission
during year 2000 to 2004 with a primary or secondary diagnosis
of acute stroke were excluded from the study. Study patients were
categorized into four stroke subtypes based on the primary diag-
nosis coded by ICD9CM: subarachnoid hemorrhage (SAH),
intracerebral hemorrhage (ICH), IS, and transient ischemic
attack (TIA).
Data Collection
Records of study patients’ hospitalization were extracted from
the hospital administrative databases. These included the index
admission (ﬁrst admission due to stroke) and all the subsequent
admissions within 1 year of the index admission because of
stroke recurrence or any cause other than DM and DM-related
complications that were identiﬁed by ICD9CM codes of 250.*
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The main outcomes of this study were the LOS, cost of the
index hospital admission, total cost of all hospital admissions
(including index admission), the mortality of index admission,
readmission due to stroke recurrence, and readmission due to
any reason other than DM and its complications. The LOS was
extracted from the hospital billing database, and the cost was
from the NHG’s ﬁnancial database, which had been standardized
across different hospitals using the same unit price on each
service and consumable item. Costs in this study were from
health care provider’s perspective. Important variables included
patient demographic characteristics of race, sex, age, and resi-
dential status; stroke subtype; all causes of hospital admission
within 3 months before index admission (yes or no); presence of
comorbid conditions, in particular, hypertension, dyslipidemia,
atrial ﬁbrillation or ﬂutter (AFF), and ischemic heart disease
(IHD); and DM. All these factors except DM were controlled as
confounders in the multiple regression models.
Statistical Analysis
The study population was divided into two groups for compari-
son: patients with DM (history of DM or fasting plasma glucose
level of >7.0 mmol/L) and patients without DM. For univariate
analysis, nonparametric Mann–Whitney U and chi-square tests
were applied to compare the differences in outcomes between the
two groups.
Health-care utilization that consisted of LOS and costs of the
hospitalizations (from hospital’s perspective) were compared
using generalized linear models (GLMs) with gamma distribution
and log link because the data were highly skewed to the right.
GLM is an extension of the linear modeling process that allows
models to be ﬁtted to data that follow probability distributions
other than the normal distribution. The exp(B) estimated from
the model represents the odds ratio (OR) of the outcomes in the
DM group, with the non-DM group as reference. Ninety-ﬁve
percent conﬁdence interval (CI) of the OR was also reported.
Cox proportional hazards models were used to estimate the
relative risk (RR) of mortality in hospital (with discharged alive
from hospital as the censoring event and death during hospital
stay as the event of interest), the RR of the 1-year readmission
due to stroke recurrence, as well as the RR of the 1-year read-
mission due to other reasons (only including patients discharged
alive in the model, with no readmission as the censoring event
and readmission as the event of interest) by adjusting the risk
factors mentioned above. The maximum likelihood approach
was used to estimate weights of the regression parameters. The
exp(B) estimated from the model represents the RR of the out-
comes in the DM group, with the non-DM group as reference.
Ninety-ﬁve percent CI of the RR was also reported.
All statistical analyses were carried out using SPSS version 15
(SPSS, Chicago, IL).P-values <0.05were considered as signiﬁcant.
Results
There were 9766 patients admitted to the three hospitals with
acute stroke during January 2005 to June 2007. Among them
were 414 (4.2%) patients with SAH, 1567 (16.0%) with ICH,
6464 (66.2%) with IS, and 1321 (13.5%) with TIA (Table 1
shows the demographic characteristics of the stroke patients with
and without DM). The overall prevalence of DM among the
patients with stroke was 38.5%. It was signiﬁcantly higher for IS
(44.4%) and TIA patients (33.8%) compared with ICH (25.0%)
and SAH (12.6%) patients (P < 0.001 by chi-square test). With
the exception of IS, the mean ages of patients with DM were
higher than non-DM patients for SAH, ICH, and TIA. Overall, Ta
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S102 Sun and Toh
there were more males than females, except in SAH where the
females largely outnumbered the males. The ethnic distribution
of stroke patients was similar to the proﬁle of the general popu-
lation in Singapore: Chinese (75.2%), Malays (13.6%), Indians
(8.8%), and others (2.4%). There was, however, disproportion-
ately more Malays and Indians among the patients with DM
compared with the non-DM group. For all stroke subtypes, the
prevalence of hypertension, dyslipidemia, and IHD was higher in
the DM group. They were also more likely to be admitted to a
hospital during the 3 months preceding the acute stroke event.
Table 2 compares the outcomes by type of stroke.
For IS and TIA, the average LOS, cost of index admission,
and total 1-year hospitalization costs of patients with DM were
signiﬁcantly higher (P < 0.001) than non-DM patients. For
average LOS, DM patients with IS and TIA stayed 1-day and
0.6-day longer, respectively, than non-DM patients. DM patients
with IS and TIA were 10% and 26% higher in cost of index
admission than the non-DM patients, respectively. There was,
however, no signiﬁcant difference in health-care utilization in
both SAH and ICH.
SAH patients with DM had a lower mortality rate by 10%
compared with non-DM patients, whereas the rate in IS patients
with DM was about 24% higher than patients without DM. The
mortality rate among TIA patients was very low: 0.1% among
non-DM patients and 0.4% among DM patients. For IS and TIA,
patients with DM were signiﬁcantly more likely to have stroke
recurrence within 1 year. This was not evident for patients with
hemorrhagic stroke. The 1-year rehospitalization rates due to
any reason other than DM and its related complications ranged
from 30.7% to 78.4%. They were signiﬁcantly higher in patients
with DM than non-DM patients for all stroke subtypes except in
ICH, which was marginally higher. Table 3 compares the out-
comes of the DM group with the non-DM group (reference) by
multivariate analyses.
After adjusting for the confounding factors of age, sex, race,
residential status (resident or not), previous admission (yes or
no), and comorbid conditions of hypertension (yes or no), dys-
lipidemia (yes or no), AFF (yes or no), and IHD (yes or no), the
DM group had signiﬁcantly poorer outcomes than the non-DM
group for all types of stroke. DM patients with IS and TIA had
20% and 17% longer LOS, respectively. ICH, IS, and TIA
patients with DM incurred higher cost during the index admis-
sion. The total 1-year hospital expenditures incurred by ICH, IS,
and TIA patients with DM were 32%, 31%, and 48% higher
than the non-DM patients, respectively.
The mortality rates during index admission for ICH and IS
patients with DM were signiﬁcantly higher than non-DM
patients. The adjusted RR for ICH was 1.37 (95% CI 1.07–
1.76), and IS was 1.44 (95% CI 1.16–1.79). Because the mortal-
ity of TIA patients was very low, TIA patients were excluded
from the multiple analysis of mortality. The RRs of stroke recur-
rence in all stroke subtypes were not signiﬁcantly different
between both groups. With the exception of TIA, the RRs for
readmission within 1 year were signiﬁcantly higher in patients
with DM than in patients with non-DM, with the highest for
SAH (RR 1.88; 95% CI 1.12–3.17).
Discussion
Stroke is one of the common macrovascular complications
among patients with DM. In several studies around the world,
the prevalence of DM among stroke patients was reported to be
6% to 23% [5–11]. In our study, the overall prevalence of DM
was as high as 38.5%, contributed mainly by patients with stroke
of ischemic origin. The stroke patients with DM had signiﬁcantly Ta
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higher prevalence of dyslipidemia and hypertension compared
with non-DM patients (P < 0.001 by chi-square tests). DM is a
well-established risk factor for IS and TIA, and a marginal risk
factor for ICH [1,2]. Hence, early screening and optimal control
of cardiovascular risk factors, including blood pressure, choles-
terol, and blood glucose levels, are essential to prevent stroke.
The RR of mortality in patients with DM was higher than in
non-DM patients, 44% higher in IS and 37% higher in ICH. This
association however was not evident in SAH. These results were
consistent with ﬁndings in other studies [5–8].
The average LOS of the index admission for patients with
DM was 20% and 17% longer for IS and TIA, respectively,
compared with those without DM, and in ICH, it was marginally
longer by 13% (P = 0.06). These results were consistent with
reports in other studies [5,6]. Lithner et al. [6] reported that 4
days after hospital admission, more stroke patients with DM
than without DM were still conﬁned to bed. DM may affect the
rate of recovery of the neurological function after a stroke. With
a longer LOS, the cost of index admission was also correspond-
ingly higher, likely because of additional treatment of DM or its
related complications and more clinical interventions.
In this study, we did not ﬁnd an association that DM increases
the risk of early stroke recurrence within 1 year in patients with
the four types of stroke. In the Copenhagen Stroke Study [5],
although patients with DM were noted to recover more slowly
than patients with no diabetes, the amount of neurological deﬁcit
at hospital discharge was equivalent between the two groups.
This may explain why the stroke recurrence rate was not affected
by DM even though the hospital LOS was longer than patients
without DM.
Readmission rates to hospital within 1 year of acute stroke for
reasons other than DM or its related complications were signiﬁ-
cantly higher in both hemorrhagic stroke and IS patients with DM
compared with those without DM, after adjusting for confound-
ing factors. The top three reasons for readmission were cardio-
vascular disease, pneumonia, and urinary tract infection (UTI). A
possible explanation could be that the patients with DM had a
higher prevalence of cardiovascular risk factors such as hyperten-
sion, dyslipidemia, and IHD, and being diabetic made them more
prone to develop chest pain and UTI, requiring a hospital admis-
sion. The costs of subsequent hospitalizations in 1 year were
signiﬁcantly higher in DM patients with ICH, IS, and TIA.
There were several limitations with this study involving the
use of administrative data. We were only able to extract and
compare the comorbid conditions of patients that were recorded
during the hospital stay. The clinical parameters indicative of the
stroke severity at onset and the functional status of patients
before or after their stroke could not be compared. Smoking
status, lifestyle practices, degree of obesity, and socioeconomic
factors that may affect the outcome of stroke patients could not
be adjusted in this study. Some patients might be lost to
follow-up when they sought treatment at other hospitals outside
the NHG or in other countries. It would be ideal if the study
period be extended to study health-care utilization and clinical
outcomes of patients over a longer period of time.
Conclusion
Stroke is a major cause of morbidity and mortality in Singapore.
This study showed that by having diabetes as a comorbid con-
dition, patients with IS, TIA, and ICH had higher mortality,
stayed longer initially in hospital, and incurred higher hospital-
ization costs in the year after index admission compared with
their counterparts without diabetes. All stroke patients with DM
except TIA are more likely to be hospitalized in the ﬁrst year
poststroke.
It is important to identify and treat medical complications
early in an attempt to reduce the morbidity and mortality asso-
ciated with stroke. This is especially pertinent for patients with
Table 3 Outcomes of patients with diabetes mellitus (DM) compared with patients without DM by type of stroke by multiple regression
Stroke type Outcome exp(B)* 95% conﬁdence interval
SAH LOS† 0.77 0.56 1.07
Cost of index admission† 0.70 0.49 1.01
Total 1-year cost† 0.77 0.54 1.09
Mortality‡ 0.78 0.43 1.42
1-year recurrence‡ 0.64 0.17 2.30
1-year readmission‡ 1.88 1.12 3.17
ICH LOS† 1.13 0.99 1.28
Cost of index admission† 1.20 1.02 1.41
Total 1-year cost† 1.32 1.12 1.56
Mortality‡ 1.37 1.07 1.76
1-year recurrence‡ 1.13 0.74 1.73
1-year readmission‡ 1.41 1.09 1.82
IS LOS† 1.20 1.15 1.25
Cost of index admission† 1.20 1.14 1.27
Total 1-year cost† 1.31 1.24 1.40
Mortality‡ 1.44 1.16 1.79
1-year recurrence‡ 1.07 0.93 1.23
1-year readmission‡ 1.20 1.09 1.32
TIA LOS† 1.17 1.07 1.26
Cost of index admission† 1.11 1.01 1.22
Total 1-year cost† 1.48 1.28 1.72
Mortality‡§ — — —
1-year recurrence‡ 1.11 0.82 1.51
1-year readmission‡ 0.99 0.79 1.25
*exp(B) is odds ratio in 1 (generalized linear model) and relative risk ratio in 2 (Cox regression).
†Generalized linear model.
‡Cox proportional hazards model.
§Multiple regression was not conducted for TIA patients as their mortality rates were very low in both DM and non-DM.
Confounding factors: age, sex, race, residential status, previous admission, and comorbid conditions of hypertension, dyslipidemia, atrial ﬁbrillation or ﬂutter, and ischemic heart disease.
ICH, intracerebral hemorrhage; IS, ischemic stroke; LOS, length of stay; SAH, subarachnoid hemorrhage;TIA, transient cerebral ischemia.
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DM. Future studies and speciﬁc interventions could be more
targeted to reduce the mortality and readmissions associated
with stroke patients with DM.
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